Isoflavones in breastfed infants after mothers consume soy

American Journal of Clinical Nutrition

Volumn 84, Issue 2, 2006, Pages 406-413

  Franke, Adrian A ^a   Halm, Brunhild M ^b   Custer, Laurie J ^a   Tatsumura, Yvonne ^a   Hebshi, Sandra ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b Kapi'olani Medical Center for Women and Children   (United States)

Author keywords

Biological markers; Breast milk; Creatinine; Infants; Isoflavones; Plasma; Soy foods; Urine

Indexed keywords

BIOLOGICAL MARKER; CREATININE; ISOFLAVONE DERIVATIVE; SOYBEAN PROTEIN;

ADULT; ARTICLE; BEVERAGE; BLOOD SAMPLING; BREAST FEEDING; BREAST MILK; CONTROLLED STUDY; DRUG BIOAVAILABILITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; MILK; NURSING; PLASMA; SOYBEAN; URINALYSIS; VENOUS BLOOD; BABY FOOD; BIOAVAILABILITY; BLOOD; CHEMISTRY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MOTHER; NEWBORN; URINE;

ADULT; BIOLOGICAL AVAILABILITY; BREAST FEEDING; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; CREATININE; FEMALE; HUMANS; INFANT; INFANT FOOD; INFANT, NEWBORN; ISOFLAVONES; MALE; MASS SPECTROMETRY; MILK, HUMAN; MOTHERS; SOY FOODS; URINALYSIS;

EID: 33748438876     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/84.1.406     Document Type: Article

References (73)

1. Umphress ST, Murphy SP, Franke AA, Custer LJ, Blitz CL. Isoflavone content of foods with soy additives. J Food Comp Anal 2005;18:533-50.
2. Franke AA, Custer LJ, Cerna CM, Narala K. Rapid HPLC analysis of dietary phytoestrogens from legumes and from human urine. Proc Soc Exp Biol Med 1995;208:18-26.
3. Adlercreutz H, Mazur W. Phyto-estrogens and Western diseases. Ann Med 1997;29:95-120.
4. Horn-Ross PL, Lee M, John EM, Koo J. Sources of phytoestrogen exposure among non-Asian women in California, USA. Cancer Causes Control 2000;11:299-302.
5. Franke AA, Custer LJ, Wang W, Shi SJ. HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc Soc Exp Biol Med 1998;217:263-73.
6. Franke AA, Custer LJ, Hundahl SA. Determinants for urinary and plasma isoflavones in humans after soy intake. Nutr Cancer 2004;50:141-54.
7. Setchell KD, Brown NM, Desai PB, et al. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr 2003;133:1027-35.
8. Zubik L, Meydani M. Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am J Clin Nutr 2003;77:1459-65.
9. Richelle M, Pridmore-Merten S, Bodenstab S, Enslen M, Offord EA. Hydrolysis of isoflavone glycosides to aglycones by beta-glycosidase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal women. J Nutr 2002;132:2587-92.
10. Hollman PCH. Absorption, bioavailability, and metabolism of flavonoids. Pharm Biol 2004;42:74-83.
11. Seow A, Shi C-Y, Franke AA, Hankin J, Lee H-P, Yu MC. Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore. Cancer Epidemiol Biomarkers Prev 1998;7:135-40.
12. Chen Z, Zheng W, Custer LJ, et al. Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoid in overnight urine samples among Chinese women in Shanghai. Nutr Cancer 1999;33:82-9.
13. Atkinson C, Skor HE, Fitzgibbons ED, et al. Overnight urinary isoflavone excretion in a population of women living in the United States, and its relationship to isoflavone intake. Cancer Epidemiol Biomarkers Prev 2002;11:253-60.
14. Grace PB, Taylor JI, Low YL, et al. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European Prospective Investigation of Cancer and Nutrition-Norfolk. Cancer Epidemiol Biomarkers Prev 2004;13:698-708.
15. Wu AH, Yu MC, Tseng CC, Twaddle NC, Doerge DR. Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County. Carcinogenesis 2004;25:77-81.
16. Fanti P, Stephenson TJ, Kaariainen IM, et al. Serum isoflavones and soya food intake in Japanese, Thai and American end-stage renal disease patients on chronic haemodialysis. Nephrol Dial Transplant 2003;18:1862-8.
17. Wiseman H, Casey K, Bowey EA, et al. Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults. Am J Clin Nutr 2004;80:692-9.
18. Ritchie MR, Morton MS, Deighton N, Blake A, Cummings JH. Plasma and urinary phyto-oestrogens as biomarkers of intake: validation by duplicate diet analysis. Br J Nutr 2004;91:447-57.
19. Messina M, Persky V, Setchell KDR, Barnes S. Soy intake and cancer risk: a review of in vitro and in vivo data. Nutr Cancer 1994;21:113-31.
20. Barnes S, Grubbs C, Setchell KDR, Carlson J. Soybeans inhibit mammary tumors in models of breast cancer. In: Pariza W, Aeschbacher U, Felton JS, Sato S, eds. Mutagens and carcinogens in the diet. New York, NY: Wiley-Liss, 1990:239-54.
21. Lamartiniere CA, Moore J, Holland M, Barnes S. Neonatal genistein chemoprevents mammary cancer. Proc Soc Exp Biol Med 1995;208:120-3.
22. Murrill WB, Brown NM, Zhang J-X, Manzolillo PA, Barnes S, Lamartiniere CA. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogen 1996;17:1451-7.
23. Pollard M, Luckert PH. Influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L-W rats. Nutr Cancer 1997;28:41-5.
24. Zhang J-X, Hallmans G, Landstrom M, et al. Soy and rye diets inhibit the development of Dunning R3327 prostatic adenocarcinoma in rats. Cancer Lett 1997;114:313-4.
25. Uckun FM, Evans WE, Forsyth CJ, et al. Biotherapy of B-cell precursor leukemia by targeting genistein to CD19- associated tyrosine kinases. Science 1995;267:886-91.
26. Sirtori CR. Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis. Drug Saf 2001;24:665-82.
27. Yeung J, Yu TF. Effects of isoflavones (soy phyto-estrogens) on serum lipids: a meta-analysis of randomized controlled trials. Nutr J 2003;2:15.
28. Hall WL, Rimbach G, Williams CM. Isoflavones and endothelial function. Nutr Res Rev 2005;18:130-44.
29. Lu LJ, Anderson KE, Grady JJ, Nagamani M. Effects of an isoflavone-free soy diet on ovarian hormones in premenopausal women. J Clin Endocrinol Metab 2001;86:3045-52.
30. Sirtori CR, Lovati MR, Manzoni C, et al. Proteins of white lupin seed, a naturally isoflavone-poor legume, reduce cholesterolemia in rats and increase LDL receptor activity in HepG2 cells. J Nutr 2004;134:18-23.
31. Gardner CD, Newell KA, Cherin R, Haskell WL. The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women. Am J Clin Nutr 2001;73:728-35.
32. Dillingham BL, McVeigh BL, Lampe JW, Duncan AM. Soy protein isolates of varying isoflavone content exert minor effects on serum reproductive hormones in healthy young men. J Nutr 2005;135:584-91.
33. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW, Jr. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998;68(suppl):1375S-9S.
34. Cline JM, Franke AA, Register TC, Golden DL, Adams MR. Effects of dietary isoflavone aglycones on the reproductive tract of male and female mice. Toxicol Pathol 2004;32:91-9.
35. Franke AA, Custer LJ. High-performance liquid chromatography assay of isoflavonoids and coumestrol from human urine. J Chromatogr B 1994;662:47-60.
36. Setchell KDR, Zimmer-Nechemias L, Cai J, Heubi JE. Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet 1997;350:23-7.
37. Cruz MLA, Wong WW, Mimouni F, et al. Effects of infant nutrition on cholesterol synthesis rates. Pediatr Res 1994;35:135-40.
38. Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 2001;108:776-89.
39. Saga K, Terao T. [Studies on transfer of vitamin K into human breast milk]. Nippon Sanka Fujinka Gakkai Zasshi 1989;41:1713-9 (in Japanese).
40. Franke AA, Custer LJ. Daidzein and genistein concentration in human milk after soy consumption. Clin Chem 1996;42:955-64.
41. Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE. Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life. Am J Clin Nutr 1998;68(suppl):1453S-61S.
42. Franke AA, Custer LJ, Tanaka Y. Isoflavones in human breast milk and other biological fluids. Am J Clin Nutr 1998;68(suppl):1466S-73S.
43. Franke AA, Hankin JH, Yu MC, Maskarinec G, Low SH, Custer LJ. Isoflavone levels in soy foods consumed by multiethnic populations in Singapore and Hawaii. J Agric Food Chem 1999;47:977-86.
44. Franke AA, Custer LJ, Wilkens LR, et al. Liquid chromatographic analysis of dietary phytoestrogens from human urine and blood. J Chromatogr B 2002;777:43-57.
45. Blair RM, Appt SE, Franke AA, Clarkson TB. Treatment with antibiotics reduces plasma equol concentration in cynomolgus monkeys (Macaca fascicularis). J Nutr 2003;133:2262-7.
46. Dai Q, Franke AA, Jin F, et al. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev 2002;11:815-21.
47. Adams MR, Golden DL, Franke AA, Potter SM, Smith HS, Anthony MS. Dietary soy beta-conglycinin (7S globulin) inhibits atherosclerosis in mice. J Nutr 2004;134:511-6.
48. Vaughan VC III, Litt IF. Growth and development. In: Behrman RE, ed. Nelson textbook of pediatrics. Philadelphia: WB Saunders, 1992:6.
49. Fomon SJ. Nutrition of normal infants. St Louis, MO: Mosby, 1993.
50. Remer T, Neubert A, Maser-Gluth C. Anthropometry-based reference values for 24-h urinary creatinine excretion during growth and their use in endocrine and nutritional research. Am J Clin Nutr 2002;75:561-9.
51. Knudsen N, Christiansen E, Brandt-Christensen M, Nygaard B, Perrild H. Age- and sex-adjusted iodine/creatinine ratio. A new standard in epidemiological surveys? Evaluation of three different estimates of iodine excretion based on casual urine samples and comparison to 24 h values. Eur J Clin Nutr 2000;54:361-3.
52. Zheng Y, Lee SO, Verbruggen MA, Murphy PA, Hendrich S. The apparent absorptions of isoflavone glucosides and aglucons are similar in women and are increased by rapid gut transit time and low fecal isoflavone degradation. J Nutr 2004;134:2534-9.
53. 13C- labeled tracers in premenopausal women. Am J Clin Nutr 2003;77:411-9.
54. Yan L, Spitznagel E. A meta-analysis of soyfoods and risk of breast cancer in women. Int J Cancer Prev 2004;1:281-93.
55. Yan L, Spitznagel EL. Meta-analysis of soy food and risk of prostate cancer in men. Int J Cancer 2005;117:667-9.
56. Hilakivi-Clarke L. Estrogens, BRCA1, and breast cancer. Cancer Res 2000;60:4993-5001.
57. Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R, Elgavish A. Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr 2002;132:552S-8S.
58. Cabanes A, Wang M, Olivo S, et al. Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis 2004;25:741-8.
59. Shu XO, Jin F, Dai Q, et al. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 2001;10:483-8.
60. Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, Pike MC. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 2002;23:1491-6.
61. Nettleton JA, Greany KA, Thomas W, Wangen KE, Adlercreutz H, Kurzer MS. Plasma phytoestrogens are not altered by probiotic consumption in postmenopausal women with and without a history of breast cancer. J Nutr 2004;134:1998-2003.
62. Kesteloot H, Joossens JV. On the determinants of the creatinine clearance: a population study. J Hum Hypertens 1996;10:245-9.
63. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 2005;113:192-200.
64. Kampmann J, Siersbaek-Nielsen K, Kristensen M, Hansen JM. Rapid evaluation of creatinine clearance. Acta Med Scand 1974;196:517-20.
65. Hoey L, Rowland IR, Lloyd AS, Clarke DB, Wiseman H. Influence of soya-based infant formula consumption on isoflavone and gut microflora metabolite concentrations in urine and on faecal microflora composition and metabolic activity in infants and children. Br J Nutr 2004;91:607-16.
66. Hall Moran V, Leathard HL, Coley J. Urinary hormone levels during the natural menstrual cycle: the effect of age. J Endocrinol 2001;170:157-64.
67. Anlyan AJ, Starr A. Beta-glucuronidase activity of spinal and ventricular fluids in humans. Cancer 1952;5:578-80.
68. Lampe JW, Li SS, Potter JD, King IB. Serum beta-glucuronidase activity is inversely associated with plant-food intakes in humans. J Nutr 2002;132:1341-4.
69. Pippin DJ, Swafford JR, McCunniff MD. Morphology of azurophil lysosomes in polymorphonuclear leukocytes from humans with rapidly progressive periodontitis. J Periodontal Res 2000;35:26-32.
70. Kroemer HK, Klotz U. Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors. Clin Pharmacokinet 1992;23:292-310.
71. Hooper LV, Midtvedt T, Gordon JI. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 2002;22:283-307.
72. Maskarinec G, Oshiro C, Morimoto Y, Hebshi S, Novotny R, Franke AA. Urinary isoflavone excretion as a compliance measure in a soy intervention among young girls: a pilot study. Eur J Clin Nutr 2005;59:369-75.
73. Maskarinec G, Singh S, Meng L, Franke AA. Dietary soy intake and urinary isoflavone excretion among women from a multiethnic population. Cancer Epidemiol Biomarkers Prev 1998;7:613-9.